logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Cushing Syndrome

    FiltersReset Filters
    6 results

    • fludrocortisone acetate

      (Fludrocortisone Acetate)
      Novitium Pharma LLC
      Usage: Fludrocortisone acetate tablets, 0.1 mg, are indicated for partial replacement therapy in primary and secondary adrenocortical insufficiency (Addison's disease) and for treating salt-losing adrenogenital syndrome.

    • fludrocortisone acetate

      (Fludrocortisone Acetate)
      NorthStar RxLLC
      Usage: Fludrocortisone acetate tablets, 0.1 mg, are indicated for partial replacement therapy in primary and secondary adrenocortical insufficiency associated with Addison’s disease and for treating salt-losing adrenogenital syndrome.

    • korlym

      (Mifepristone)
      Corcept Therapeutics Incorporated
      Usage: KORLYM (mifepristone) is indicated for controlling hyperglycemia caused by hypercortisolism in adults with endogenous Cushing's syndrome who have type 2 diabetes or glucose intolerance and are not surgical candidates. It is not intended for type 2 diabetes unrelated to Cushing's syndrome.

    • prednisone

      (Prednisone)
      Actavis Pharma, Inc.
      Usage: Prednisone is indicated for various conditions, including endocrine disorders (e.g., adrenal insufficiency), rheumatic disorders, collagen diseases, severe dermatologic and allergic conditions, ophthalmic diseases, respiratory issues, hematologic disorders, some neoplastic diseases, edematous states, gastrointestinal diseases, and critical conditions like tuberculous meningitis.

    • prednisone

      (PredniSONE)
      Hikma Pharmaceuticals USA Inc.
      Usage: Prednisone tablets are indicated for various conditions including endocrine disorders (adrenocortical insufficiency), rheumatic disorders (arthritis), collagen diseases (lupus), dermatologic diseases (pemphigus), severe allergic conditions, ophthalmic diseases, respiratory diseases (sarcoidosis), hematologic disorders, neoplastic diseases (leukemia), edematous states, gastrointestinal diseases (colitis), and neurological exacerbations.

    • recorlev

      (Levoketoconazole)
      Xeris Pharmaceuticals, Inc.
      Usage: RECORLEV is indicated for treating endogenous hypercortisolemia in adults with Cushing’s syndrome when surgery is not an option or has not been curative. It is not approved for fungal infections, and its safety and effectiveness for such uses are not established.